全文获取类型
收费全文 | 2534篇 |
免费 | 112篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 86篇 |
妇产科学 | 25篇 |
基础医学 | 200篇 |
口腔科学 | 72篇 |
临床医学 | 130篇 |
内科学 | 669篇 |
皮肤病学 | 67篇 |
神经病学 | 187篇 |
特种医学 | 210篇 |
外科学 | 438篇 |
综合类 | 13篇 |
预防医学 | 78篇 |
眼科学 | 22篇 |
药学 | 138篇 |
中国医学 | 5篇 |
肿瘤学 | 301篇 |
出版年
2023年 | 7篇 |
2022年 | 24篇 |
2021年 | 41篇 |
2020年 | 22篇 |
2019年 | 39篇 |
2018年 | 53篇 |
2017年 | 39篇 |
2016年 | 41篇 |
2015年 | 49篇 |
2014年 | 75篇 |
2013年 | 72篇 |
2012年 | 148篇 |
2011年 | 163篇 |
2010年 | 77篇 |
2009年 | 81篇 |
2008年 | 162篇 |
2007年 | 160篇 |
2006年 | 164篇 |
2005年 | 165篇 |
2004年 | 155篇 |
2003年 | 140篇 |
2002年 | 146篇 |
2001年 | 82篇 |
2000年 | 58篇 |
1999年 | 64篇 |
1998年 | 33篇 |
1997年 | 31篇 |
1996年 | 20篇 |
1995年 | 24篇 |
1994年 | 15篇 |
1993年 | 8篇 |
1992年 | 37篇 |
1991年 | 24篇 |
1990年 | 24篇 |
1989年 | 21篇 |
1988年 | 16篇 |
1987年 | 24篇 |
1986年 | 20篇 |
1985年 | 14篇 |
1984年 | 15篇 |
1983年 | 11篇 |
1982年 | 8篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1979年 | 7篇 |
1978年 | 12篇 |
1977年 | 9篇 |
1975年 | 7篇 |
1974年 | 5篇 |
1973年 | 5篇 |
排序方式: 共有2658条查询结果,搜索用时 12 毫秒
111.
Youko Horikawa‐Kyo MD Takeo Tanaka MD Hirofumi Tanano MD Yasuhiro Kitayama MD Shuhei Karakawa MD Kiyomi Taniyama MD 《Pediatric blood & cancer》2009,53(2):206-207
Mediastinal hemangiopericytoma (HPC) was diagnosed in a 3‐year‐old female. The incidence of this tumor is rare in children, and few data are available to guide clinical management. The surgical resection was incomplete and she received adjuvant radiation therapy and chemotherapy. The patient is alive without adverse events 6 years after diagnosis. Pediatr Blood Cancer 2009;53:206–207. © 2009 Wiley‐Liss, Inc. 相似文献
112.
The development of the dauer form of Caenorhabditis elegans daf-2(e1370) enhances the expression of genes such as fatty acid desaturase fat-6 and fat-7 and fatty acid elongase elo-2, and increases the level of triglyceride (TAG). RNA interference (RNAi) of the fat-6, fat-7, and elo-2 genes lowers fat accumulation in the nematode. We recently clarified the fact that RNAi of fat-related genes, especially fat-2, reduced fat accumulation and activated DAF-16. 相似文献
113.
Kokichi Sugano Seigo Nakamura Jiro Ando Shin Takayama Hiroyuki Kamata Isao Sekiguchi Megumi Ubukata Tetsuro Kodama Masami Arai Fujio Kasumi Yasuo Hirai Tadashi Ikeda Hiromitsu Jinno Masaki Kitajima Daisuke Aoki Akira Hirasawa Yuko Takeda Kumiko Yazaki Takashi Fukutomi Takayuki Kinoshita Ryuichiro Tsunematsu Teruhiko Yoshida Masako Izumi Shino Umezawa Hiroshi Yagata Hiroko Komatsu Naoko Arimori Noriko Matoba Nobuhisa Gondo Shiro Yokoyama Yoshio Miki 《Cancer science》2008,99(10):1967-1976
The prevalence of BRCA1/2 germline mutations in Japanese patients suspected to have hereditary breast/ovarian cancer was examined by a multi‐institutional study, aiming at the clinical application of total sequencing analysis and validation of assay sensitivity in Japanese people using a cross‐sectional approach based on genetic factors estimated from personal and family histories. One hundred and thirty‐five subjects were referred to the genetic counseling clinics and enrolled in the study. Full sequencing analysis of the BRCA1/2 gene showed 28 types of deleterious mutations in 36 subjects (26.7%), including 13 types of BRCA1 mutations in 17 subjects (12.6%) and 15 types of BRCA2 mutations in 19 subjects (14.1%). Subjects were classified into five groups and 22 subgroups according to their personal and family history of breast and/or ovarian cancer, and the prevalence of deleterious mutations was compared with previously reported data in non‐Ashkenazi individuals. Statistical analysis using the Mantel‐Haenszel test for groups I through IV revealed that the prevalence of Japanese subjects was significantly higher than that of non‐Ashkenazi individuals (P = 0.005, odds ratio 1.87, 95% confidence interval 1.22–2.88). Family history of the probands suffering from breast cancer indicated risk factors for the presence of deleterious mutations of BRCA1/2 as follows: (1) families with breast cancer before age 40 within second degree relatives (P = 0.0265, odds ratio 2.833, 95% confidence interval 1.165–7.136) and (2) families with bilateral breast cancer and/or ovarian cancer within second degree relatives (P = 0.0151, odds ratio 2.88, 95% confidence interval 1.25–6.64). (Cancer Sci 2008; 99: 1967–1976) 相似文献
114.
Since 1990, laparoscopic surgery for gastrointestinal disease has been accepted worldwide because it is minimally invasive, associated with less pain, and results in early recovery. For the surgical management of gastroesophageal reflux and perforated peptic ulcer, laparoscopic procedures are recognized as the standard. Laparoscopic gastrectomies for cancer have developed since 1991. Laparoscopic wedge resection and intragastric mucosal resection are performed for the treatment of early gastric cancer without the risk of lymph node metastasis. For early gastric cancer with the risk of perigastric lymph node metastasis, laparoscopy-assisted Billroth-I gastrectomy with D1 lymph node dissection has been successfully performed. Thus, laparoscopic approaches play an important role in the management of gastroduodenal disease. 相似文献
115.
Effects of mild hypothermia and alkalizing agents on brain injuries in rats with acute subdural hematomas 总被引:3,自引:0,他引:3
Brain ischemia is the leading pathopysiological mechanism in the development of secondary brain damage after acute subdural hematoma (SDH). Hypothermia has been employed as an effective cerebroprotective treatment on brain injuries, but the control of the general condition is very difficult under hypothermia, and various severe complications have been reported. Cerebral acidosis in the ischemic area is one of the important factors augmenting the brain edema formation. Tris-(hydroxymethyl)-aminomethane (THAM) has been used as an alkalizing agent for acidosis on brain injury and is reported to be effective. In the present study, we used a rat acute SDH model to assess the effect of mild (35 degrees C) hypothermia and THAM combined treatment on brain water content, brain ischemia, and blood-brain barrier (BBB) permeability at 4 h after hematoma induction. Mild hypothermia did not significantly reduce the brain water content beneath the hematoma (79.5 +/- 0.2%) compared to normothermia (80.2 +/- 0.2%), but mild hypothermia combined to THAM resulted in a significant reduction (78.7 +/- 0.0%; p < 0.01). Combined with mild hypothermia, THAM treatment significantly reduced the Evan's blue extravasation (35 +/- 7 ng/g wet tissue; p < 0.05) compared to normothermia (63 +/- 7 ng/g wet tissue). Furthermore, the volume of infarction at 24 h after the hematoma induction (54 +/- 3 mm(3); p < 0.01) was significantly smaller by the combined treatment compared with normothermia (70 +/- 2 mm(3)). The present findings indicate that mild hypothermia of 35 degrees C combined with THAM presents a potent cerebroprotective strategy. The protection of the BBB is one of the possible cerebroprotective mechanisms in this rat acute SDH model. 相似文献
116.
Inhibitory effect of bucillamine on laser-induced choroidal neovascularization in rats 总被引:1,自引:0,他引:1
Hikichi T Mori F Sasaki M Takamiya A Nakamura M Shishido N Takeda M Horikawa Y Matsuoka H Yoshida A 《Current eye research》2002,24(1):1-5
PURPOSE: We investigated the inhibitory effects of bucillamine on formation of laser-induced choroidal neovascularization (CNV) in a rat model. METHODS: Bucillamine administration (approximately 150 mg/kg/day) was started 1 week before photocoagulation and continued to the end of the study. Control groups received drinking water. Two weeks after photocoagulation, choroidal neovascularization development was evaluated using simultaneous fluorescein and indocyanine green angiography, and the maximal thickness of the lesions was measured histologically. RESULTS: The incidence of CNV formation was 99.5 +/- 0.2% [mean +/- standard deviation (SD)] in control rats and 64.3 +/- 15.1% with bucillamine (P < 0.01). Histological study showed that the thickness of the CNV lesions was 23.4 +/- 6.5 microm (mean +/- SD) in the bucillamine-treated rats, which was significantly decreased compared to that in controls (60.8 +/- 9.2 microm) (P < 0.01). CONCLUSIONS: Our results suggest that bucillamine may inhibit the development of laser-induced CNV in rats. 相似文献
117.
Comparison of Lp82- and m-calpain-mediated proteolysis during cataractogenesis in Shumiya cataract rat (SCR) 总被引:1,自引:0,他引:1
Inomata M Hayashi M Ito Y Matsubara Y Takehana M Kawashima S Shumiya S 《Current eye research》2002,25(4):207-213
PURPOSE: It is well known that m-calpain, a ubiquitous calpain, is involved in cataract formation in rodent lens. Involvement of Lp82, a lens-specific calpain, in the cataract formation is also suggested. However, the exact relationship between Lp82-mediated proteolysis and lens opacification has not yet been established. We therefore compared Lp82- and m-calpain-mediated proteolyses of alphaA-crystallin during cataractogenesis to clarify whether Lp82 is involved in cataract formation. METHODS: In order to analyze the Lp82- and m-calpain-mediated proteolyses, we developed antibodies exclusively specific to the proteolytic products of alphaA-crystallin produced by Lp82 and m-calpain actions, respectively. The proteolytic profiles of alphaA-crystallin by Lp82 and m-calpain during cataractogenesis in SCR lenses were analyzed by Western blotting and immunohistochemical staining. RESULTS: While m-calpain-mediated proteolysis was detected predominantly in cataractous lenses, Lp82-mediated proteolysis was detected not only in cataractous but in normal lenses. The m-calpain-mediated proteolysis was observed in restricted areas developing and destined to develop opacification, i.e., the nuclear and perinuclear regions of lens. On the other hand, Lp82-mediated proteolysis was observed not only in the same regions but also in the cortical region where opacity does not develop. Unlike m-calpain-mediated proteolysis, Lp82-mediated proteolysis was not inhibited by the oral administration of aminoguanidine (AG), which acts to prevent lens opacification. CONCLUSIONS: From these results, it is shown that there is no direct contribution of Lp82-mediated proteolysis to cataract formation in SCR. Rather, Lp82 may function in fiber cell development and/or fiber cell remodeling during lens maturation under physiological conditions, since Lp82-mediated proteolysis occurs in the cortical region of normal lens. 相似文献
118.
Sunakawa K Nonoyama M Fujii R Iwai N Sakata H Shirai M Sato T Kajino M Toyonaga Y Sano T Naito A Minagawa K Niida Y Oda T Yokozawa M Asanuma H Shimura K Fujimura M Kitajima H Fujinami K Numazaki K Fujikawa T Kobayashi Y Sato Y Nishimura T Iwata S Tsuchihashi N Oishi T Matsumoto S Motohiro T Osawa M Sunahara M Shirakawa S Nishida H Takahashi N Nakano R Sai N Iyoda K Yoshimitsu K Ogawa K Okazaki T Tsukimoto I Motoyama O Takada Y Kawasaki M Sunaoshi W Nakamura S Ueda Y Kamata M Kato T Chiba M 《The Japanese journal of antibiotics》2002,55(5):656-677
Pharmacokinetics, clinical efficacy and safety of teicoplanin (TEIC) were evaluated in pediatric and neonate patients with MRSA sepsis in the dosages approved in overseas. The administrated dose for pediatrics patients was 10 mg/kg once at hour 0, 12 and 24, followed by every 24 hours intervals. In neonates patients, first dose was 16 mg/kg, then 8 mg/kg every 24 hours intervals. 1. Pharmacokinetic results. All 17 patients (9 neonates and 8 pediatrics) who received TEIC were evaluated for pharmacokinetics. Trough concentrations were analyzed in 16 patients (9 neonates and 7 pediatrics) excluding one patient for lack of measurement of drug concentration at day 7. No patient with a concentration exceeding 60 micrograms/mL in peak or trough concentrations were reported. Mean concentrations in trough at day 3, 4 and 7 in neonates were 15.2, 14.7 and 17.8 micrograms/mL, and in pediatrics were 12.5, 12.2 and 13.1 micrograms/mL, respectively. These results were similar to those reported in foreign pediatrics and neonates patients. 2. Efficacy and safety results. Since no patient was excluded, all patients were evaluated for efficacy and safety. Microbiological efficacy as well as clinical cure were secondarily evaluated in 2 patients for whom MRSA was isolated from blood. Clinical efficacy rate was 76.5% (13/17) and number of cases in judgments of excellent, good, fairly improved and no change were 12, 1, 3 and 1 cases respectively. The patients for whom MRSA was isolated from blood were judged as MRSA eradicated case and cured without any additional anti-MRSA drugs. Adverse events were reported in 2 neonates and 3 pediatric patients. Possibly related adverse events to study drug (adverse drug reactions) were: 1 case of respiratory disorder, thrombocythemia, gamma-GTP increased, GOT increased and GPT increased in 3 pediatrics. These results suggest that an application of overseas dose regimen of TEIC for neonate and pediatrics is appropriate in Japan. 相似文献
119.
Koizumi M Nishimura N Enami T Sunaga M Horikawa H Kamata E Hasegawa R 《The Journal of toxicological sciences》2002,27(5):411-421
Repeated dose toxicity of 3-aminophenol was examined on oral administration to newborn and young rats, and susceptibility was analyzed in terms of the no observed adverse effect level (NOAEL) and the unequivocally toxic level. In the 18-day newborn rat study, starting at day 4 after birth, tremors and depression of body weight gain were observed, as well as hypertrophy of thyroid follicular epithelial cells and increases of relative liver and kidney weights at 240 mg/kg. Increase of relative liver weights in males and decrease of blood sugar in females without any histopathological changes at 80 mg/kg were not considered to be adverse effects. No chemical-related changes were observed at 24 mg/kg. Abnormalities of external development and reflex ontogeny in the newborn were not observed. In the 28-day study, starting at 5 weeks of age, depression of body weight gain, tremors, anemia, and liver, kidney and thyroid toxicity were observed at 720 mg/kg. Although slight pigmentation in the renal proximal tubular epithelium was observed in females at 240 mg/kg, this was not considered to be an adverse effect because of the lack of changes in related toxicological parameters. It was concluded that the NOAEL is 80 mg/kg/day in newborn rats and 240 mg/kg/day in young rats, with unequivocally toxic levels of 240 mg/kg/day and 720 mg/kg/day, respectively. Based on these two endpoints, the susceptibility of newborn rats to the chemical was approx. 3 times higher than that of young rats, consistent with our previous results for 4-nitrophenol and 2,4-dinitrophenol. 相似文献
120.